Is there a need for emerging drugs for the acute respiratory distress syndrome?
- PMID: 25152048
- PMCID: PMC4284055
- DOI: 10.1517/14728214.2014.953052
Is there a need for emerging drugs for the acute respiratory distress syndrome?
Abstract
The acute respiratory distress syndrome (ARDS) is a common and devastating syndrome of acute respiratory failure for which little effective pharmacotherapy exists. The authors describe some interventions that show promise as potential therapies for this condition, with particular reference to clinically relevant human models of ARDS. Aspirin, mesenchymal stromal (stem) cells, keratinocyte growth factor, IFN-β and oncostatin M inhibition are discussed.
Keywords: IFN-β; acute respiratory distress syndrome; aspirin; mesenchymal stromal cells; oncostatin M.
Conflict of interest statement
M Fitzgerald receives funding from the Belfast Health and Social Care Trust Research and Development Office, as well as the Intensive Care Society of Ireland. DF McAuley has undertaken paid consultancy work and has been a member of advisory boards on ARDS for GlaxoSmithKline. This author’s institution has been paid for the author to undertake bronchosocopy as part of a clinical trial funded by GlaxoSmithKline. DF McAuley has a patent submitted for a novel treatment for ARDS, and is the chief investigator of a multi-center study investigating simvastatin as a therapy for ARDS (funded by the National Institute for Health and Research), chief investigator of a single center study investigating aspirin in ARDS (funded by the Northern Ireland Research and Development Office) and chief investigator of a single center study investigating aspirin in a model of ARDS (ARENA, NCT01659307; funded by the UK Intensive Care Society). DF McAuley acknowledges funding from the Northern Ireland Public Health Agency Research and Development Division Translational Research Group for Critical Care. M Matthay acknowledges grant support (NHLBI R37 HL51856).
Similar articles
-
Emerging drugs for treating the acute respiratory distress syndrome.Expert Opin Emerg Drugs. 2019 Mar;24(1):29-41. doi: 10.1080/14728214.2019.1591369. Epub 2019 Mar 18. Expert Opin Emerg Drugs. 2019. PMID: 30841764 Review.
-
Emerging pharmacological therapies for ARDS: COVID-19 and beyond.Intensive Care Med. 2020 Dec;46(12):2265-2283. doi: 10.1007/s00134-020-06141-z. Epub 2020 Jul 11. Intensive Care Med. 2020. PMID: 32654006 Free PMC article.
-
Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: current and experimental approaches.Drugs. 2010 Jul 9;70(10):1255-82. doi: 10.2165/10898570-000000000-00000. Drugs. 2010. PMID: 20568833 Free PMC article. Review.
-
Pathogenesis of Acute Respiratory Distress Syndrome.Semin Respir Crit Care Med. 2019 Feb;40(1):31-39. doi: 10.1055/s-0039-1683996. Epub 2019 May 6. Semin Respir Crit Care Med. 2019. PMID: 31060086 Free PMC article. Review.
-
Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.J Intensive Care Med. 2006 May-Jun;21(3):119-43. doi: 10.1177/0885066606287045. J Intensive Care Med. 2006. PMID: 16672636 Free PMC article. Review.
Cited by
-
Evaluation of interleukin-1 and interleukin-6 receptor antagonists in a murine model of acute lung injury.Exp Physiol. 2024 Jun;109(6):966-979. doi: 10.1113/EP091682. Epub 2024 Apr 9. Exp Physiol. 2024. PMID: 38594909 Free PMC article.
-
Extracorporeal membrane oxygenation (ECMO) and the acute respiratory distress syndrome (ARDS): a systematic review of pre-clinical models.Intensive Care Med Exp. 2019 Mar 25;7(1):18. doi: 10.1186/s40635-019-0232-7. Intensive Care Med Exp. 2019. PMID: 30911932 Free PMC article. Review.
-
Neutrophils promote alveolar epithelial regeneration by enhancing type II pneumocyte proliferation in a model of acid-induced acute lung injury.Am J Physiol Lung Cell Mol Physiol. 2016 Dec 1;311(6):L1062-L1075. doi: 10.1152/ajplung.00327.2016. Epub 2016 Sep 30. Am J Physiol Lung Cell Mol Physiol. 2016. PMID: 27694472 Free PMC article.
-
Ablation of PDE4B protects from Pseudomonas aeruginosa-induced acute lung injury in mice by ameliorating the cytostorm and associated hypothermia.FASEB J. 2021 Sep;35(9):e21797. doi: 10.1096/fj.202100495R. FASEB J. 2021. PMID: 34383981 Free PMC article.
-
Dexamethasone fails to improve bleomycin-induced acute lung injury in mice.Physiol Rep. 2019 Nov;7(21):e14253. doi: 10.14814/phy2.14253. Physiol Rep. 2019. PMID: 31724341 Free PMC article.
References
-
- Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet. 1967;2(7511):319–23. The landmark first description of acute respiratory distress syndrome (ARDS) as a clinical entity, based on a case series of 12 patents. - PubMed
-
- Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 Pt 1):818–24. Internationally recognised expert consensus definition of ARDS, for the first time bringing some standardisation to its description, allowing greater conformity in the literature, but with some controversial areas. Superseded by the Berlin definition. - PubMed
-
- Force ADT, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–33. The most recent definition of ARDS, aiming to further clarify and standardise definition and care. Widely accepted, though some controversy persists. - PubMed
-
- Thompson BT, Matthay MA. The Berlin definition of ARDS versus pathological evidence of diffuse alveolar damage. Am J Respir Crit Care Med. 2013;187(7):675–7. Editorial discussing the findings of the Thille paper (ref 5 below) with reference to the Berlin definition of ARDS, and exploring the strenghths and limitations of this definition. - PubMed
-
- Thille AW, Esteban A, Fernandez-Segoviano P, et al. Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy. Am J Respir Crit Care Med. 2013;187(7):761–7. Interesting post mortem study of 712 patients over two decades, investigating pathological patterns of injury in ARDS, and comparing the findings with the stratifications of the Berlin definition. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources